Myelofibroses

DBCOND0092673Hemic and Lymphatic DiseasesNeoplasms

Myelofibroses is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Primary Myelofibrosis · Myelofibrosis · Agnogenic Myeloid Metaplasia · Idiopathic Myelofibrosis · Primary Myelofibrosis (PMF)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0519745ICD-10D47.4SNOMED CT119031000119101MedDRA10028537UMLSC0001815

What you can answer from here — as of November 07, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
532Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Myelofibroses share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In